UFPT - Mergers and acquisitions

NEWBURYPORT, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisitions of Universal Plastics & Engineering Company, Inc. ("UNIPEC") and Techno Plastics Industries, Inc. ("TPI"). These transactions further expand UFP's capabilities in tight tolerance film components and thermoplastic molding for the medical device market. UNIPEC, headquartered in Rockville, Maryland, develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in C

NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Welch Fluorocarbon Inc. Founded in 1985 and headquartered in Dover, New Hampshire, Welch Fluorocarbon develops and manufactures thermoformed, and heat sealed implantable medical device components utilizing thin, high-performance films. "Welch Fluorocarbon will bring significant thin film thermoforming capabilities to our expanding MedTech portfolio of technologies and materials," said R. Jeffrey Bailly, chairman and C

NEWBURYPORT, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AJR Enterprises, LLC. Headquartered in St. Charles, Illinois, with additional manufacturing in the Dominican Republic, AJR Enterprises develops and manufactures single use safe patient handling systems. "We are very excited to add AJR Enterprises' capabilities to our patient surfaces portfolio," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Patient surfaces and transfer devices are a growing market due

NEWBURYPORT, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Advant Medical Ltd. Founded in 1993 and headquartered in Galway, Ireland, with operations in Costa Rica and partner manufacturing in Mexico, Advant Medical is a developer and manufacturer of Class I, II, and III medical devices and packaging.    "We are pleased to be joining forces with Advant, our third major acquisition in six months," said R. Jeffrey Bailly, Chairman and CEO. "It's an excellent cultural and strategic fit that i

NEWBURYPORT, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of DAS Medical, Inc. Founded in 2010 and headquartered in Atlanta, Georgia, with manufacturing in the Dominican Republic, DAS is a medical device contract manufacturer specializing in the design, development and production of single-use surgical equipment covers, robotic draping systems and fluid control pouches. "Adding DAS Medical to the UFP MedTech portfolio is another important step in our growth strategy," said R. Jeffrey Bailly,

NEWBURYPORT, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the acquisition of Contech Medical, Inc. Founded in 1987 and headquartered in Providence, Rhode Island, with partner manufacturing in Costa Rica, Contech Medical is a global leader in the design, development, and manufacture of class III medical device packaging primarily for catheters and guidewires. Annual sales are approximately $18 million. "We are very pleased to add a new and differentiated medical technology to our growing portfolio," said R.